Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-26-000240
Filing Date
2026-04-07
Accepted
2026-04-07 16:58:42
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9290
  Complete submission text file 0000898432-26-000240.txt   11245
Mailing Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070
Business Address 18805 COX AVENUE SUITE 250 SARATOGA CA 95070 (408) 370-4790
CapsoVision, Inc (Subject) CIK: 0001378325 (see all company filings)

EIN.: 203369494 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-95270 | Film No.: 26845585
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 25TH FL, 97 TUN HWA S RD SEC 2 DA-AN DIST. TAIPEI Taiwan 106
Business Address 25TH FL, 97 TUN HWA S RD SEC 2 DA-AN DIST. TAIPEI Taiwan 106 886-2-2325-7998
CID Greater China Venture Capital Fund III, L.P. (Filed by) CIK: 0002092240 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A